Home4503 • TYO
Astellas Pharma Inc
Â¥1,510.00
Jan 10, 6:15:00 PM GMT+9 · JPY · TYO · Disclaimer
StockGLeaf logoClimate leaderJP listed securityJP headquartered
Previous close
Â¥1,536.00
Day range
¥1,507.00 - ¥1,535.50
Year range
¥1,426.00 - ¥1,835.00
Market cap
2.73T JPY
Avg Volume
5.37M
P/E ratio
49.64
Dividend yield
4.77%
Primary exchange
TYO
CDP Climate Change Score
A
Financials
Income Statement
Revenue
Net income
(JPY)Sep 2024Y/Y change
Revenue
462.50B17.94%
Operating expense
341.78B7.88%
Net income
35.91B1,239.35%
Net profit margin
7.761,041.18%
Earnings per share
——
EBITDA
88.05B120.73%
Effective tax rate
6.85%—
Total assets
Total liabilities
(JPY)Sep 2024Y/Y change
Cash and short-term investments
292.99B-12.28%
Total assets
3.46T-2.28%
Total liabilities
1.93T1.51%
Total equity
1.53T—
Shares outstanding
1.79B—
Price to book
1.80—
Return on assets
2.64%—
Return on capital
3.70%—
Net change in cash
(JPY)Sep 2024Y/Y change
Net income
35.91B1,239.35%
Cash from operations
64.81B75.72%
Cash from investing
-16.38B97.88%
Cash from financing
-54.34B-110.76%
Net change in cash
-9.94B95.63%
Free cash flow
43.59B-17.69%
About
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Founded
Apr 1, 2005
Employees
14,754
Search
Clear search
Close search
Google apps
Main menu